ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48 | -36.0% | 15,027 | 0.0% | 0.00% | – |
| Q2 2023 | $75 | +2400.0% | 15,027 | +2708.8% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 535 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 535 | +28.6% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 416 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -53.8% | 416 | -14.6% | 0.00% | – |
| Q3 2021 | $13,000 | +85.7% | 487 | +74.6% | 0.00% | – |
| Q2 2021 | $7,000 | -30.0% | 279 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | +42.9% | 279 | +5.7% | 0.00% | – |
| Q4 2020 | $7,000 | -76.7% | 264 | -66.5% | 0.00% | – |
| Q3 2020 | $30,000 | +130.8% | 787 | +14.4% | 0.00% | – |
| Q2 2020 | $13,000 | 0.0% | 688 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | -27.8% | 688 | 0.0% | 0.00% | – |
| Q4 2019 | $18,000 | – | 688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |